One possible explanation that researchers uncovered in immunotherapy-resistant HCC murine models is that tumor cell intrinsic upregulation of PPARγ transcriptionally activated VEGF-A production, which drove MDSC expansion and CD8+ T cell dysfunction [50]. This evidence concerns the gene PPARG and hepatocellular carcinoma.